天安卓健(00383)发布公告，于2025年8月28日斥资8500港元回购股份1万股。 ...

Group 1 - The company Tianan Health (00383) announced a share buyback plan, intending to repurchase 10,000 shares at a cost of HKD 8,500 [1]

Group 1 - The company Tianan Health (00383.HK) announced a share buyback plan [1] - The buyback will occur on August 28, 2025, for a total of 10,000 shares [1] - The repurchase price is set at HKD 0.85 per share, totaling HKD 8,500 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) | | | FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 表格類別： 股票 狀態： 新提交 公司名稱： 天安卓健有限公司 呈交日期： 2025年8月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股 ...

Core Insights - Yunnan Province is advancing the integration of green electricity and advanced manufacturing, with a focus on building zero-carbon parks and promoting high-quality regional economic development through clean energy transmission [1][2] Group 1: Green Energy Development - Yunnan's total power generation capacity exceeds 160 million kilowatts, with over 90% from clean energy and nearly 40% from renewable sources [1] - The province has a new energy storage capacity exceeding 5 million kilowatts, and industries such as green aluminum, silicon photovoltaic, and new energy batteries are expanding [1] Group 2: Green Certificate System - Yunnan is enhancing its green energy development efforts, with green electricity trading volume reaching 1.6 billion kilowatt-hours last year [1] - The province aims for full coverage of green certificate issuance, with 240 million green certificates issued by the end of July this year [1][2] - The efficiency of data collection for green certificate issuance has improved by 60% due to government-enterprise collaboration [2] Group 3: Policy and Implementation - A joint implementation plan has been released by Yunnan's Development and Reform Commission, Industrial and Information Technology Department, and Energy Bureau to promote local conversion of green electricity resources [2] - The plan outlines six pathways to deepen the integration of green electricity with advanced manufacturing, facilitating the green and low-carbon transformation of industries [2]

Group 1 - The article provides an overview of the investment activities of Hong Kong-listed companies on August 11, 2025, including new stock activities, earnings announcements, shareholder meetings, and dividend distributions [1] Group 2 - New stock activities include companies such as ZhiNuo Pharmaceutical-B (currently in the IPO process) and Zhonghui Biotechnology-B (listing date) [1] - Earnings announcements are scheduled for companies like Baosheng International, Yuanyuan Group, and Kang Shifu Holdings among others [1] - Shareholder meetings will be held for companies including Huatai Textile, Shandong Gold, and Sichuan Chengyu Expressway [1] - Dividend distributions are noted for companies like Jianbei Miao Miao and Kangnait Optical, with specific ex-dividend and payment dates mentioned [1]

Core Viewpoint - Tianan Health (00383) reported a decline in revenue and profit for the six months ending June 30, 2025, primarily due to decreased operational income in the medical segment and increased non-cash fair value losses on investment properties [1] Financial Performance - The company achieved revenue of HKD 783 million, a year-on-year decrease of 4.67% [1] - Profit attributable to shareholders was HKD 11.979 million, down 44.69% year-on-year [1] - Basic earnings per share were HKD 0.0111 [1] Contributing Factors - The decline in revenue and profit was mainly attributed to reduced operational income in the medical segment [1] - There was an increase in non-cash fair value losses on investment properties [1] - However, this decline was partially offset by a reduction in employee benefit expenses, net unrealized exchange gains, and decreased income tax expenses [1]

Core Viewpoint - Tianan Health (00383) announced that Dr. Wang Yongquan will succeed Mr. Jiang Muxian as the chairman of the nomination committee starting from August 1, 2025, while Mr. Jiang will remain a member of the nomination committee [1] Group 1 - Dr. Wang Yongquan is currently a member of the company's nomination committee [1] - Mr. Jiang Muxian will continue to serve as a member of the nomination committee after his transition [1]

Core Viewpoint - Tianan Health (00383) reported a decline in revenue and profit for the six months ending June 30, 2025, primarily due to decreased operational income in the medical segment and increased non-cash fair value losses on investment properties [1] Financial Performance - The company achieved revenue of HKD 783 million, representing a year-on-year decrease of 4.67% [1] - Profit attributable to shareholders was HKD 11.979 million, down 44.69% year-on-year [1] - Basic earnings per share were HKD 0.0111 [1] Contributing Factors - The decline in revenue and profit was mainly attributed to reduced operational income in the medical segment [1] - There was an increase in non-cash fair value losses on investment properties [1] - The decrease in employee benefit expenses and the recognition of unrealized foreign exchange gains offset some losses [1] - The company experienced a reduction in income tax expenses compared to the first half of 2024, which also contributed to mitigating the overall decline [1]

Core Viewpoint - Tian Andru Health (00383) announced that Dr. Wang Yongquan will succeed Mr. Jiang Muxian as the Chairman of the Nomination Committee starting from August 1, 2025, while Mr. Jiang will remain a member of the committee [1] Group 1 - Dr. Wang Yongquan is currently a member of the company's Nomination Committee [1] - Mr. Jiang Muxian will continue to serve as a member of the Nomination Committee after his transition [1]